| Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study M Dobre, W Yang, J Chen, P Drawz, LL Hamm, E Horwitz, T Hostetter, ... American Journal of Kidney Diseases 62 (4), 670-678, 2013 | 268 | 2013 |
| Chronic kidney disease P Drawz, M Rahman Annals of internal medicine 150 (3), ITC2-1-1, 2009 | 258* | 2009 |
| Chronic kidney disease P Drawz, M Rahman Annals of internal medicine 150 (3), ITC2-1-1, 2009 | 258* | 2009 |
| Chronic kidney disease P Drawz, M Rahman Annals of internal medicine 162 (11), ITC1-ITC1, 2015 | 230 | 2015 |
| Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage PE Drawz, AB Alper, AH Anderson, CS Brecklin, J Charleston, J Chen, ... Clinical Journal of the American Society of Nephrology 11 (4), 642-652, 2016 | 208 | 2016 |
| Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (Systolic Blood Pressure Intervention Trial … PE Drawz, NM Pajewski, JT Bates, NA Bello, WC Cushman, JP Dwyer, ... Hypertension 69 (1), 42-50, 2017 | 189 | 2017 |
| Prevalence and prognostic significance of apparent treatment resistant hypertension in chronic kidney disease: report from the chronic renal insufficiency cohort study G Thomas, D Xie, HY Chen, AH Anderson, LJ Appel, S Bodana, ... Hypertension 67 (2), 387-396, 2016 | 177 | 2016 |
| Heart rate and blood pressure: any possible implications for management of hypertension? S Reule, PE Drawz Current hypertension reports 14, 478-484, 2012 | 153 | 2012 |
| Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use RLP Jump, DM Olds, N Seifi, G Kypriotakis, LA Jury, EP Peron, AA Hirsch, ... Infection Control & Hospital Epidemiology 33 (12), 1185-1192, 2012 | 145 | 2012 |
| Effects of intensive blood pressure treatment on acute kidney injury events in the Systolic Blood Pressure Intervention Trial (SPRINT) MV Rocco, KM Sink, LC Lovato, DF Wolfgram, TB Wiegmann, BM Wall, ... American Journal of Kidney Diseases 71 (3), 352-361, 2018 | 130 | 2018 |
| Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel P Muntner, PT Einhorn, WC Cushman, PK Whelton, NA Bello, PE Drawz, ... Journal of the American College of Cardiology 73 (3), 317-335, 2019 | 129 | 2019 |
| Blood pressure measurement: clinic, home, ambulatory, and beyond PE Drawz, M Abdalla, M Rahman American Journal of Kidney Diseases 60 (3), 449-462, 2012 | 129 | 2012 |
| Metabolic complications in elderly adults with chronic kidney disease PE Drawz, DC Babineau, M Rahman Journal of the American Geriatrics Society 60 (2), 310-315, 2012 | 126 | 2012 |
| Kidney disease among patients with sickle cell disease, hemoglobin SS and SC P Drawz, S Ayyappan, M Nouraie, S Saraf, V Gordeuk, T Hostetter, ... Clinical Journal of the American Society of Nephrology 11 (2), 207-215, 2016 | 107 | 2016 |
| Heart rate variability is a predictor of mortality in chronic kidney disease: a report from the CRIC Study PE Drawz, DC Babineau, C Brecklin, J He, RR Kallem, EZ Soliman, D Xie, ... American journal of nephrology 38 (6), 517-528, 2014 | 107 | 2014 |
| APOL1-G0 or APOL1-G2 transgenic models develop preeclampsia but not kidney disease LA Bruggeman, Z Wu, L Luo, SM Madhavan, M Konieczkowski, PE Drawz, ... Journal of the American Society of Nephrology 27 (12), 3600-3610, 2016 | 94 | 2016 |
| TNFR2 interposes the proliferative and NF-κB-mediated inflammatory response by podocytes to TNF-α LA Bruggeman, PE Drawz, N Kahoud, K Lin, L Barisoni, PJ Nelson Laboratory investigation 91 (3), 413-425, 2011 | 89 | 2011 |
| CKD as a model for improving chronic disease care through electronic health records PE Drawz, P Archdeacon, CJ McDonald, NR Powe, KA Smith, J Norton, ... Clinical Journal of the American Society of Nephrology 10 (8), 1488-1499, 2015 | 85 | 2015 |
| Trends in angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use among those with impaired kidney function in the United States DP Murphy, PE Drawz, RN Foley Journal of the American Society of Nephrology 30 (7), 1314-1321, 2019 | 84 | 2019 |
| Kidney damage biomarkers and incident chronic kidney disease during blood pressure reduction: a case–control study WR Zhang, TE Craven, R Malhotra, AK Cheung, M Chonchol, P Drawz, ... Annals of internal medicine 169 (9), 610-618, 2018 | 79 | 2018 |
